Your session is about to expire
← Back to Search
ECMO for ARDS (ULTIMATE Trial)
ULTIMATE Trial Summary
This trial is testing whether using a specific type of ventilation (ultra-protective ventilation) with ECMO support can help improve outcomes for people with early moderate-severe ARDS, compared to using the best current conventional ventilation.
ULTIMATE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ULTIMATE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You weigh more than your height in centimeters plus one kilogram.Your medical team is focusing on providing comfort and relief for your symptoms, rather than trying to cure your illness.You were on a breathing machine through a tube in your throat for no more than 5 days.You are extremely ill and not expected to survive beyond the next 24 hours, even with life-supporting treatments.You cannot take medication to prevent blood clots because you have a high risk of bleeding or have active bleeding in your stomach or intestines.You cannot participate if you are pregnant because we don't know how changes in PaCO2 levels will affect blood flow to the placenta.You use a machine to help you breathe at home, not just a CPAP machine.
- Group 1: Ultra-protective ventilation with ECMO
- Group 2: Best conventional ventilation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open enrollments for this clinical trial currently being accepted?
"Per the clinicaltrials.gov platform, this investigation is not currently enrolling volunteers. The trial was inaugurated on June 1st 2021 and concluded its recruitment phase in April of that year. Despite no longer accepting participants for the current study, there are still 90 active trials recruiting patients at present."
What is the aim of this research endeavor?
"The primary assesment of this two year trial is the adherence to its protocol. Secondary measures include occurrences of non-pulmonary organ dysfunction, barotrauma incidents, and changes in quality of life as quantified by EQ-5D telephone interviews."
How many health care facilities are conducting this research endeavor?
"This medical trial is running at 15 sites, with New york Presbyterian Hospital in the Big Apple, University of Alberta Hospital in Edmonton and OHSU hospital in Portland being amongst them."
Share this study with friends
Copy Link
Messenger